These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 16827136)
1. COX-2 inhibitors celecoxib and rofecoxib prevent oxidative DNA fragmentation. Matthias C; Schuster MT; Zieger S; Harréus U Anticancer Res; 2006; 26(3A):2003-7. PubMed ID: 16827136 [TBL] [Abstract][Full Text] [Related]
2. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026 [TBL] [Abstract][Full Text] [Related]
3. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone. Wang BH; Bertucci MC; Ma JY; Adrahtas A; Cheung RY; Krum H Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):912-8. PubMed ID: 20497423 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors. Navidpour L; Amini M; Shafaroodi H; Abdi K; Ghahremani MH; Dehpour AR; Shafiee A Bioorg Med Chem Lett; 2006 Sep; 16(17):4483-7. PubMed ID: 16806914 [TBL] [Abstract][Full Text] [Related]
6. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro]. Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633 [TBL] [Abstract][Full Text] [Related]
7. Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels? Aw TJ; Liew D; Tofler GH; Schneider HG; Morel-Kopp MC; Billah B; Krum H J Hypertens; 2006 Oct; 24(10):1979-84. PubMed ID: 16957557 [TBL] [Abstract][Full Text] [Related]
8. Reduction of DNA damage by curcumin and celecoxib in epithelial cell cultures of the oropharynx after incubation with tobacco smoke condensate. Reiter M; Baumeister P; Boeck D; Schwenk-Zieger S; Harréus U Anticancer Res; 2012 Aug; 32(8):3185-9. PubMed ID: 22843891 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of selective COX-2 inhibitors. Süleyman H; Demircan B; Karagöz Y; Oztaşan N; Süleyman B Pol J Pharmacol; 2004; 56(6):775-80. PubMed ID: 15662090 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitor. Okumura T; Murata Y; Hizue M; Matsuura T; Naganeo R; Kanai Y; Murase A; Sakakibara A; Fujita I; Nakao K Eur J Pharmacol; 2006 Jun; 539(1-2):125-30. PubMed ID: 16690052 [TBL] [Abstract][Full Text] [Related]
11. The anti-proliferative potency of celecoxib is not a class effect of coxibs. Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro. Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548 [TBL] [Abstract][Full Text] [Related]
13. Celecoxib induces regression of putative preneoplastic lesions in rat liver. Arellanes-Robledo J; Márquez-Rosado L; Pérez-Carreón JI; Fattel-Fazenda S; Aguirre-García J; Villa-Treviño S Anticancer Res; 2006; 26(2A):1271-80. PubMed ID: 16619534 [TBL] [Abstract][Full Text] [Related]
14. Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma. Barlow M; Edelman M; Glick RD; Steinberg BM; Soffer SZ J Pediatr Surg; 2012 Jun; 47(6):1223-7. PubMed ID: 22703797 [TBL] [Abstract][Full Text] [Related]
15. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Olivares C; Bilotas M; Buquet R; Borghi M; Sueldo C; Tesone M; Meresman G Hum Reprod; 2008 Dec; 23(12):2701-8. PubMed ID: 18716040 [TBL] [Abstract][Full Text] [Related]
17. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism. Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386 [TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells. Lou J; Fatima N; Xiao Z; Stauffer S; Smythers G; Greenwald P; Ali IU Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1598-606. PubMed ID: 16985019 [TBL] [Abstract][Full Text] [Related]
19. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760 [TBL] [Abstract][Full Text] [Related]
20. Modulation of ionizing radiation-induced G2 arrest by cyclooxygenase-2 and its inhibitor celecoxib. Jun HJ; Kim YM; Park SY; Park JS; Lee EJ; Choi SA; Pyo H Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):225-34. PubMed ID: 19695440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]